Paladin Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$820K Buy
10,485
+245
+2% +$19.8K 0.48% 63
2026
Q1
$887K Sell
10,240
-490
-5% -$46.9K 0.61% 51
2025
Q4
$1.03M Sell
10,730
-499
-4% -$48.5K 0.7% 45
2025
Q3
$1.07M Sell
11,229
-346
-3% -$31.8K 0.78% 47
2025
Q2
$1.01M Buy
11,575
+560
+5% +$47.5K 0.78% 42
2025
Q1
$990K Buy
11,015
+330
+3% +$29.5K 0.89% 44
2024
Q4
$854K Buy
10,685
+1,917
+22% +$166K 0.74% 44
2024
Q3
$789K Buy
+8,768
New +$738K 0.69% 52

Other funds holding MDT

Paladin Wealth's MDT Position: Q2 2026 in Review

Paladin Wealth increased its Medtronic (MDT) stake by 2.4% in Q2 2026, buying an estimated $19.8K and bringing the position to 10,485 shares worth $820K. The position accounts for 0.48% of the portfolio, ranked #63.

Paladin Wealth first reported a position in MDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.07M in Q3 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Paladin Wealth held 10,485 shares of Medtronic worth $820K as of Q2 2026.
  • Paladin Wealth bought 245 Medtronic shares in Q2 2026, an estimated $19.8K.
  • Medtronic made up 0.48% of Paladin Wealth's portfolio in Q2 2026, its #63 holding.
  • Paladin Wealth first reported a position in Medtronic in Q3 2024 and has held it in 8 quarters since.
  • Paladin Wealth's Medtronic position peaked at $1.07M in Q3 2025.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Paladin Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.